Updated Medicare Coverage
The Oncotype DX Genomic Prostate Score test is now covered by Medicare for favorable intermediate-risk prostate cancer.
When Amy was diagnosed with breast cancer, she was scared. Her Oncotype DX Breast DCIS Score result made her feel in control.
Ineffective cancer treatments exact human as well financial costs. Oncotype IQ tests have saved more than $3.5 billion in the US.
The Eighth Edition AJCC Staging Manual will go into effect in 2018, and it will change staging for T1-2 N0 M0 breast cancer patients.
Latest TAILORx Data
After 5 years, 95% of women with a low Oncotype DX Breast Recurrence Score result were recurrence-free with hormone therapy alone.
Sign up for Our Healthcare Professional Updates